Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation
暂无分享,去创建一个
S. Bentzen | M. Baer | A. Emadi | R. Lapidus | A. Duffy | Y. Zou | N. Ambulos | Jennie Y Law | Sunil Adige | Brandon A. Carter-Cooper | Ciera L. Patzke